Diagnosis and evaluation of dementia

Neurology

Volumn 45, Issue 2, 1995, Pages 211-218

  Corey Bloom, Jody ^a   Thai, L J ^a   Galasko, D ^a   Folstein, M ^b   Drachman, D ^c   Raskind, M ^d   Lanska, D J ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALZHEIMER DISEASE; COGNITIVE DEFECT; DETERIORATION; DIAGNOSTIC ACCURACY; HEALTH CARE COST; HUMAN; MEDICAL RECORD; MENTAL HEALTH; MULTIINFARCT DEMENTIA; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

DEMENTIA; DIAGNOSIS, DIFFERENTIAL; HUMAN; MEDICAL HISTORY TAKING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; QUESTIONNAIRES;

EID: 0028819091     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.45.2.211     Document Type: Review

References (118)

1. Folstein M, Anthony JC, Parhad I, Duffy B, Gruenberg EM. The meaning of cognitive impairment in the elderly. J Am Geriatr Soc 1985;33:228-233.
2. United States Congress, Office of Technology Assessment. Losing a million minds: confronting the tragedy of Alzheimer’s disease and other dementias. Washington, DC: 1987.
3. Pfeffer RI, Afifi AA, Chance JM. Prevalence of Alzheimer’s disease in a retirement community. Am J Epidemiol 1987;125:420-436.
4. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer’s disease in a community population of older persons. JAMA 1989;262:2551-2556.
5. Evans DA, Scherr PA, Cook NR, et al. Estimated prevalence of Alzheimer’s disease in the United States. Milbank Q 1990;68:267-287.
6. Huang LF, Cartwright WS, Hu TW. The economic cost of senile dementia in the United States. Public Health Report 1988;103:3-7.
7. Katzman R. The prevalence and malignancy of Alzheimer disease: a major killer. Arch Neurol 1976;33:217-218.
8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed, revised. Washington, DC: American Psychiatric Association, 1987.
9. Morris JC, McKeel DW, Storandt M, et al. Very mild Alzheimer’s disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 1991;41:469-478.
10. McKhann G, Drachmann D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34: 939-944.
11. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology 1992;42:473-480.
12. Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
13. Storandt M, Botwinick J, Danziger WL, Berg L, Hughes CP. Psychometric differentiation of mild senile dementia of the Alzheimer type. Arch Neurol 1984;41:497-499.
14. Eslinger PJ, Damasio AR, Benton AL, Van Allen M. Neuropsychologic detection of abnormal mental decline in older persons. JAMA 1985;253:670-674.
15. Huff FJ, Becker JT, Belle SH, Nebes RD, Holland AL, Boiler F. Cognitive deficits and clinical diagnosis of Alzheimer’s disease. Neurology 1987;37:1119-1124.
16. Tierney MC, Snow WG, Reid DW, Zorzitto ML, Fisher RH. Psychometric differentiation of dementia: replication and extension of the findings of Storandt and coworkers. Arch Neurol 1987;44:720-722.
17. Storandt M, Hill RD. Very mild senile dementia of the Alzheimer type: II. Psychometric test performance. Arch Neurol 1989;46:383-386.
18. Pfeffer RI, Kurosaki TT, Harrah CH, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol 1982;37:323-329.
19. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
20. Anthony JC, LeResch L, Niaz U, Von Korff M, Folstein M. Limits of the ‘Mini Mental State’ as a screening test for dementia and delirium among hospital patients. Psychol Med 1982;12:397-408.
21. Thal LJ, Grundman M, Goldaen R. Alzheimer’s disease: a correlational analysis of the Blessed Information-Memory- Concentration Test and the Mini-Mental State Exam. Neurology 1986;36:262-264.
22. Fillenbaum GG, Heyman A, Wilkinson WE, Haynes CS. Comparison of two screening tests in Alzheimer’s disease: the correlation and reliability of the Mini-Mental State Examination and the modified Blessed test. Arch Neurol 1987;44:924-927.
23. Magaziner J, Bassett SS, Hebei JR. Predicting performance on the Mini-Mental State Examination: use of age- and education-specific equations. J Am Geriatr Soc 1987;35:996-1000.
24. Teng EL, Chui HC. The modified Mini-Mental State (3MS) Examination. J Clin Psychiatry 1987;48:314-318.
25. Bleecker ML, Bolla-Wilson K, Kawas C, Agnew J. Age-specific norms for the Mini-Mental State Exam. Neurology 1988;38:1565-1568.
26. Galasko D, Klauber MR, Hofstetter CR, Salmon DP, Lasker B, Thal LJ. The Mini-Mental State Examination in the early diagnosis of Alzheimer’s disease. Arch Neurol 1990;47:49-52.
27. Giordani B, Boivin MJ, Hall AL, et al. The utility and generality of Mini-Mental State Examination scores in Alzheimer’s disease. Neurology 1990;40:1894-1896.
28. Hadar U, Rose FC. Neuropsychological assessment of cognitive change in dementia. Neuroepidemiology 1990;9:189-192.
29. Heeren TJ, Lagaay AM, von Beek WCA, Rooymans HGM, Hijmans W. Reference values for the Mini-Mental State Examination (MMSE) in octo- and nonagenarians. J Am Geriatr Soc 1990;38:1093-1096.
30. Murden RA, McRae TD, Kaner S, Bucknam ME. Mini-Mental State Exam scores vary with education in blacks and whites. J Am Geriatr Soc 1991;39:149-155.
31. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797-811.
32. Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short orientation-memory-concentra- tion test of cognitive impairment. Am J Psychiatry 1983;140:734-739.
33. Davous P, Lamour Y, Debrand E, Rondot P. A comparative evaluation of the short orientation memory concentration test of cognitive impairment. J Neurol Neurosurg Psychiatry 1987;50:1312-1317.
34. Katzman R, Aronson M, Fuld P, et al. Development of dementia in an 80-year-old volunteer cohort. Ann Neurol 1989;25:317-324.
35. Burnam MA, Karno M, Hough RL, Escobar JI, Forsythe AB. The Spanish Diagnostic Interview schedule: reliability and comparison with clinical diagnosis. Arch Gen Psychiatry 1983;40:1189-1196.
36. Holzer CE, Tischler GL, Leaf PJ, Myers JK. An epidemiologic assessment of cognitive impairment in a community population. Res Commun Ment Health 1983;4:3-32.
37. Uhlmann RF, Larson EB. Effects of education on the MiniMental State Examination as a screening test for dementia. J Am Geriatr Soc 1991;39:876-880.
38. Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia, a cause of mental deterioration in the elderly. Lancet 1974;2:207-210.
39. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of Ischemic Score in differentiation of dementias. Ann Neurol 1980;7:486-488.
40. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:53-63.
41. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
42. Smith JS, Kiloh LG. The investigation of dementia: results in 200 consecutive admissions. Lancet 1981;2:824-827.
43. Larson EB, Reifler BV, Featherstone HJ, English DR. Dementia in elderly outpatients: a prospective study. Ann Intern Med 1984;100:417-423.
44. Larson EB, Reifler BV, Sumi SM, Canfield CG, Chinn NM. Diagnostic tests in the evaluation of dementia: a prospective study of 200 elderly outpatients. Arch Intern Med 1986;146:1917-1922.
45. Clarfield AM. The reversible dementias: do they reverse? Ann Intern Med 1988;109:476-486.
46. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein t4 allelle in patients with Alzheimer’s disease. Ann Neurol 1993;34:752-754.
47. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allelle e4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 1993;43:1467-1472.
48. Jellinger K. Neuropathological aspects of dementias resulting from abnormal blood and cerebrospinal fluid dynamics. Acta Neurol Belg 1976;76:83-102.
49. Wells CE. Diagnostic evaluation and treatment in dementia. In: Wells CE, ed. Dementia. 2nd ed. Philadelphia: FA Davis, 1977:247-276.
50. Bradshaw JR, Thomson JLG, Campbell MJ. Computed tomography in the investigation of dementia. Br Med J 1983;286:277-280.
51. Dietch JT. Computerized tomographic scanning in cases of dementia. West J Med 1983;138:835-837.
52. Katzman R. Should a major imaging procedure (CT or MRI) be required in the workup of dementia? An affirmative view. J Fam Pract 1990;31:401-410.
53. Erkinjuntti T, Lee DH, Gao F, et al. Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer’s disease. Arch Neurol 1993;50:305-310.
54. Becker PM, Feussner JR, Mulrow CD, Williams BC, Vokaty KA. The role of lumbar puncture in the evaluation of dementia: the Durham Veterans Administration/Duke University study. J Am Geriatr Soc 1985;33:392-396.
55. Hammerstrom DC, Zimmer B. The role of lumbar puncture in the evaluation of dementia: the University of Pittsburgh study. J Am Geriatr Soc 1985;33:397-400.
56. Ghanbari HA, Miller BE, Haigler HJ, et al. Biochemical assay of Alzheimer’s disease-associated protein(s) in human brain tissue. JAMA 1990;263:2907-2910.
57. Van Nostrand WE, Wagner SL, Shankle WR, et al. Decreased levels of soluble amyloid a-protein precursor in cerebrospinal fluid of live Alzheimer disease patients. Proc Natl Acad Sei USA 1992;89:2551-2555.
58. Chase TN, Foster NCL, Fedio P, Brooks R, Mansi L, Chiro GD. Regional cortical dysfunction in Alzheimer’s disease as determined by positron emission tomography. Ann Neurol 1984;15(suppl 1):5170-5174.
59. Friedland RP, Budinger TF, Brant-Zawadski M, Jagust WJ. The diagnosis of Alzheimer’s-type dementia. JAMA 1988;252:2750-2752.
60. Jagust WJ, Reed BR, Seab JP, Budinger TF. Alzheimer’s disease: age at onset and single-photon emission computed tomographic patterns of regional cerebral blood flow. Arch Neurol 1990;47:628-633.
61. Johnson KA, Holman BL, Rosen J, Nagel JS, English RJ, Growden JH. Iofetamine I123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer’s disease. Arch Intern Med 1990;150:752-756.
62. Fazekas F, Alavi A, Chawluk JB, Zimmerman RA, Hackney D, Bilaniuk L. Comparison of CT, MR, and PET in Alzheimer’s dementia and normal aging. J Nucl Med 1989;30:1607-1615.
63. Duara R, Grady C, Haxby J, et al. Positron emission tomography in Alzheimer’s disease. Neurology 1986;36:879-887.
64. Jagust WJ, Friedland RP, Budinger TF, Koss E, Ober B. Longitudinal studies of regional cerebral metabolism in Alzheimer’s disease. Neurology 1988;38:909-912.
65. Powers WJ, Perlmutter JS, Videen TO, et al. Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer’s disease. Neurology 1992;42:765-770.
66. Katzman R, Lasker B, Bernstein N. Advances in the diagnosis of dementia: accuracy of diagnosis and consequences of misdiagnosis of disorders causing dementia. In: Terry RD, ed. Aging and the brain. New York: Raven Press, 1988:17-62.
67. Helkala E-L, Laulumaa V, Soininen H, Partanen J, Riekki- nen PJ. Different patterns of cognitive decline related to normal or deteriorating EEG in a 3-year follow-up study of patients with Alzheimer’s disease. Neurology 1991;41:528-532.
68. Ron MA, Toone BK, Garralda ME, et al. Diagnostic accuracy in presenile dementia. Br J Psychiatry 1979;134:161-168.
69. Amaducci L, Falcini M, Lippi A. Descriptive epidemiology and risk factors for Alzheimer’s disease. Acta Neurol Scand Suppl 1992;139:21-25.
70. Cummings JL, Miller B, Hill MA, Neshkes R. Neuropsychiatrie aspects of multi-infarct dementia and dementia of the Alzheimer type. Arch Neurol 1987;44:389-393.
71. Thal LJ, Grundman M, Klauber MR. Dementia: characteristics of a referral population and factors associated with progression. Neurology 1988;38:1083-1090.
72. Boiler F, Lopez OL, Moossy J. Diagnosis of dementia: clini- copathologic correlations. Neurology 1989;39:76-79.
73. Berg L, Smith DS, Morris JC, et al. Mild senile dementia of the Alzheimer type: 3. Longitudinal and cross-sectional assessment. Ann Neurol 1990;28:648-652.
74. Teri L, Larson EB, Reifler BV. Behavioral disturbances in dementia of the Alzheimer’s type. J Am Geriatr Soc 1988;36:1-6.
75. Drevets WC, Rubin EH. Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type. Biol Psychiatry 1989;25:39-48.
76. Wragg RE, Jeste DV. Overview of depression and psychosis in Alzheimer’s disease. Am J Psychiatry 1989;146: 577-587.
77. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer’s disease. II. Disorders of perception. Br J Psychiatry 1990;157:76-81.
78. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer’s disease. IV. Disorders of behavior. Br J Psychiatry 1990;157:86-94.
79. Rosen J, Zubenko GS. Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer’s disease. Biol Psychiatry 1991;29:224-232.
80. Sulkava R. Alzheimer’s disease and senile dementia of Alzheimer type. Acta Neurol Scand 1982;65:636-650.
81. Seltzer B, Sherwin I. A comparison of clinical features in early- and late-onset primary degenerative dementia. Arch Neurol 1984;40:143-146.
82. Chui HC, Teng EL, Henderson VW, Moy AC. Clinical subtypes of dementia of the Alzheimer type. Neurology 1985;35:1544-1550.
83. Chandra V, Bharucha NE, Schoenberg BS. Conditions associated with Alzheimer’s disease at death: case-control study. Neurology 1986;36:209-211.
84. Hauser WA, Morris ML, Heston LL, Anderson VE. Seizures and myoclonus in patients with Alzheimer’s disease. Neurology 1986;36:1226-1230.
85. Neary D, Snowden JS, Bowen DM, et al. Cerebral biopsy in the investigation of presenile dementia due to cerebral atrophy. J Neurol Neurosurg Psychiatry 1986;49:157-162.
86. Heyman A, Wilkinson WE, Hurwitz JB, et al. Early-onset Alzheimer’s disease: clinical predictors of institutionalization and death. Neurology 1987;37:980-984.
87. Bird TD, Sumi SM, Nemens EJ, et al. Phenotypic heterogeneity in familial Alzheimer’s disease: a study of 24 kindreds. Ann Neurol 1989;25:12-25.
88. Risse SC, Lampe TH, Bird TD, et al. Myoclonus, seizures, and paratonia in Alzheimer disease. Alzheimer Dis Assoc Disord 1990;4:217-225.
89. Koller WC, Glatt S, Wilson RS, Fox JH. Primitive reflexes and cognitive function in the elderly. Ann Neurol 1982;12:302-304.
90. Huff FJ, Growden JH. Neurological abnormalities associated with severity of dementia in Alzheimer’s disease. Can J Neurol Sei 1986;13:403-405.
91. Bakchine S, Lacomblez L, Palisson E, Laurent M, De- rouesne C. Relationship between primitive reflexes, extrapyramidal signs, reflexive apraxia, and severity of cognitive impairment in dementia of the Alzheimer type. Acta Neurol Scand 1989;79:38-46.
92. Huff FJ, Belle SH, Shim YK, Ganguli M, Boiler F. Prevalence and prognostic value of neurologic abnormalities in Alzheimer’s disease. Dementia 1990;1:32-40.
93. Pearce J. The extrapyramidal disorder of Alzheimer’s disease. Eur Neurol 1974;12:94-103.
94. Mölsä PK, Marttila RJ, Rinne UK. Extrapyramidal signs in Alzheimer’s disease. Neurology 1984;34:1114-1116.
95. Mayeux R, Stern Y, Spanton S. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 1985;35:453-461.
96. Stem Y, Mayeux R, Sano M, Hauser WA, Bush T. Predictors of disease course in patients with probable Alzheimer’s disease. Neurology 1987;37:1649-1653.
97. Visser H. Gait and imbalance in senile dementia of Alzheimer’s type. Age Ageing 1983;12:296-301.
98. Koller WC, Wilson RS, Glatt SL, Fox JH. Motor signs are infrequent in dementia of the Alzheimer type. Ann Neurol 1984;16:514-515.
99. Duffy P, Mayeux R, Kupsky W. Familial Alzheimer’s disease with myoclonus and “spongy change.” Arch Neurol 1988;45:1097-1100.
100. Kaye JA, May C, Atack JR, et al. Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer’s disease. Ann Neurol 1988;24:647-650.
101. Tierney MC, Fisher RH, Lewis AJ, et al. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer’s disease: a clinicopathologic study of 57 cases. Neurology 1988;38:359-364.
102. Kukull WA, Larson EB, Reifler BV, Lampe TH, Yerby MS, Hughes JP. The validity of 3 clinical diagnostic criteria for Alzheimer’s disease. Neurology 1990;40:1364-1369.
103. Risse SC, Raskind MA, Nochlin D, et al. Neuropathological findings in patients with clinical diagnoses of probable Alzheimer’s disease. Am J Psychiatry 1990;147:168-172.
104. Thai L, Galasko D, Katzman R, et al. Patients clinically assessed at an Alzheimer’s center generally have Alzheimer’s pathology [abstract]. Neurology 1991;41(suppl 1):323.
105. del Ser T, Bermejo F, Portera A, Arredondo JM, Bouras C, Constantinidis J. Vascular dementia: a clinicopathological study. J Neurol Sci 1990;96:1-17.
106. Bucht G, Adolfson R, Winblad B. Dementia of the Alzheimer type and multi-infarct dementia: a clinical description and diagnostic problems. J Am Geriatr Soc 1984;32:491-497.
107. Reding M, Haycox J, Blass J. Depression in patients referred to a dementia clinic. Arch Neurol 1985;42:894-896.
108. Molsa PK, Paljarvi L, Rinne JO, Rinne UK, Sako E. Validity of clinical diagnosis in dementia: a prospective clinicopathological study. J Neurol Neurosurg Psychiatry 1985;48:1085-1090.
109. Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau A. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem pathological study. J Neurol Neurosurg Psychiatry 1988;51:1037-1044.
110. Wade JPH, Mirsen TR, Hachinski VC, Fishman M, Lau C, Merskey H. The clinical diagnosis of Alzheimer’s disease. Arch Neurol 1987;44:24-29.
111. Loeb C, Gandolfo C. Diagnostic evaluation of degenerative and vascular dementia. Stroke 1983;14:399-401.
112. Fischer P, Jellinger K, Gatterer G, Danielczyk W. Prospective neuropathological validation of Hachinski’s Ischemic Score in dementias. J Neurol Neurosurg Psychiatry 1991;54:580-583.
113. Liston EH, LaRue A. Clinical differentiation of primary degenerative dementia and multi-infarct dementia: a critical review of the evidence. Biol Psychiatry 1983;18:1451-1484.
114. Jellinger K, Danielczyk W, Fischer P, Gabriel E. Clinicopathological analysis of dementia disorders in the elderly. J Neurol Sci 1990;95:239-258.
115. Sulkava R, Haltia M, Paetau A, Wikstrom J, Palo J. Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. J Neurol Neurosurg Psychiatry 1983;46:9-13.
116. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
117. Reisberg B, Ferris S, de Leon MJ, Crook T. The Global Deterioration Scale (GDS): an instrument for the assessment of primary degenerative dementia (PDD). Am J Psychiatry 1982;139:1136-1139.
118. Galasko D, Corey-Bloom J, Thai L. Monitoring progression in Alzheimer’s disease. J Am Geriatr Soc 1991;39:932-941.